Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ITGR vs NVCR vs LIVN vs ANIK vs LAKE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ITGR
Integer Holdings Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$3.03B
5Y Perf.+11.0%
NVCR
NovoCure Limited

Medical - Instruments & Supplies

HealthcareNASDAQ • JE
Market Cap$1.92B
5Y Perf.-75.0%
LIVN
LivaNova PLC

Medical - Devices

HealthcareNASDAQ • GB
Market Cap$3.88B
5Y Perf.+32.6%
ANIK
Anika Therapeutics, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$203M
5Y Perf.-54.8%
LAKE
Lakeland Industries, Inc.

Apparel - Manufacturers

Consumer CyclicalNASDAQ • US
Market Cap$106M
5Y Perf.-25.2%

ITGR vs NVCR vs LIVN vs ANIK vs LAKE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ITGR logoITGR
NVCR logoNVCR
LIVN logoLIVN
ANIK logoANIK
LAKE logoLAKE
IndustryMedical - DevicesMedical - Instruments & SuppliesMedical - DevicesMedical - DevicesApparel - Manufacturers
Market Cap$3.03B$1.92B$3.88B$203M$106M
Revenue (TTM)$1.85B$674M$1.43B$116M$193M
Net Income (TTM)$142M$-173M$107M$-11M$-38M
Gross Margin23.3%75.2%67.5%58.6%34.8%
Operating Margin10.4%-27.2%13.4%-10.5%-7.2%
Forward P/E13.5x16.8x
Total Debt$1.40B$290M$473M$24M$32M
Cash & Equiv.$17M$103M$636M$57M$17M

ITGR vs NVCR vs LIVN vs ANIK vs LAKELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ITGR
NVCR
LIVN
ANIK
LAKE
StockMay 20May 26Return
Integer Holdings Co… (ITGR)100111.0+11.0%
NovoCure Limited (NVCR)10025.0-75.0%
LivaNova PLC (LIVN)100132.6+32.6%
Anika Therapeutics,… (ANIK)10045.2-54.8%
Lakeland Industries… (LAKE)10074.8-25.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: ITGR vs NVCR vs LIVN vs ANIK vs LAKE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ITGR leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. LivaNova PLC is the stronger pick specifically for recent price momentum and sentiment and operational efficiency and capital deployment. LAKE also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ITGR
Integer Holdings Corporation
The Income Pick

ITGR carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • beta 0.72
  • 165.1% 10Y total return vs LIVN's 46.2%
  • Better valuation composite
  • 7.7% margin vs NVCR's -25.7%
Best for: income & stability and long-term compounding
NVCR
NovoCure Limited
The Healthcare Pick

NVCR lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
LIVN
LivaNova PLC
The Momentum Pick

LIVN is the #2 pick in this set and the best alternative if momentum and efficiency is your priority.

  • +63.0% vs LAKE's -33.3%
  • 4.2% ROA vs LAKE's -17.0%, ROIC 11.5% vs -5.1%
Best for: momentum and efficiency
ANIK
Anika Therapeutics, Inc.
The Defensive Pick

ANIK is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.14, Low D/E 16.9%, current ratio 4.72x
  • Beta 1.14, current ratio 4.72x
Best for: sleep-well-at-night and defensive
LAKE
Lakeland Industries, Inc.
The Growth Play

LAKE ranks third and is worth considering specifically for growth exposure.

  • Rev growth 34.1%, EPS growth -437.5%, 3Y rev CAGR 12.2%
  • 34.1% revenue growth vs ANIK's -5.9%
  • 1.1% yield; the other 4 pay no meaningful dividend
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthLAKE logoLAKE34.1% revenue growth vs ANIK's -5.9%
ValueITGR logoITGRBetter valuation composite
Quality / MarginsITGR logoITGR7.7% margin vs NVCR's -25.7%
Stability / SafetyITGR logoITGRBeta 0.72 vs NVCR's 2.20, lower leverage
DividendsLAKE logoLAKE1.1% yield; the other 4 pay no meaningful dividend
Momentum (1Y)LIVN logoLIVN+63.0% vs LAKE's -33.3%
Efficiency (ROA)LIVN logoLIVN4.2% ROA vs LAKE's -17.0%, ROIC 11.5% vs -5.1%

ITGR vs NVCR vs LIVN vs ANIK vs LAKE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ITGRInteger Holdings Corporation
FY 2025
Cardio And Vascular
59.7%$1.1B
Cardiac Rhythm Management & Neuromodulation
36.1%$669M
Other Markets
4.2%$78M
NVCRNovoCure Limited

Segment breakdown not available.

LIVNLivaNova PLC
FY 2025
Cardiopulmonary Segment
57.0%$785M
Neuromodulation Segment
43.0%$593M
ANIKAnika Therapeutics, Inc.
FY 2023
Joint Preservation and Restoration
84.8%$55M
Non-Orthopedic
15.2%$10M
LAKELakeland Industries, Inc.
FY 2014
Corporate Segment
100.0%$4M

ITGR vs NVCR vs LIVN vs ANIK vs LAKE — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLIVNLAGGINGLAKE

Income & Cash Flow (Last 12 Months)

LIVN leads this category, winning 3 of 6 comparable metrics.

ITGR is the larger business by revenue, generating $1.8B annually — 15.9x ANIK's $116M. ITGR is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to NVCR's -25.7%. On growth, LIVN holds the edge at +14.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricITGR logoITGRInteger Holdings …NVCR logoNVCRNovoCure LimitedLIVN logoLIVNLivaNova PLCANIK logoANIKAnika Therapeutic…LAKE logoLAKELakeland Industri…
RevenueTrailing 12 months$1.8B$674M$1.4B$116M$193M
EBITDAEarnings before interest/tax$328M-$165M$220M-$7M-$11M
Net IncomeAfter-tax profit$142M-$173M$107M-$11M-$38M
Free Cash FlowCash after capex$168M-$48M$161M$1M-$16M
Gross MarginGross profit ÷ Revenue+23.3%+75.2%+67.5%+58.6%+34.8%
Operating MarginEBIT ÷ Revenue+10.4%-27.2%+13.4%-10.5%-7.2%
Net MarginNet income ÷ Revenue+7.7%-25.7%+7.5%-9.5%-19.4%
FCF MarginFCF ÷ Revenue+9.1%-7.1%+11.2%+0.9%-8.2%
Rev. Growth (YoY)Latest quarter vs prior year+0.8%+12.3%+14.3%+13.2%+4.0%
EPS Growth (YoY)Latest quarter vs prior year+172.7%-100.0%+106.7%-8.8%-165.0%
LIVN leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — ITGR and LAKE each lead in 2 of 6 comparable metrics.

On an enterprise value basis, ITGR's 13.1x EV/EBITDA is more attractive than LIVN's 15.4x.

MetricITGR logoITGRInteger Holdings …NVCR logoNVCRNovoCure LimitedLIVN logoLIVNLivaNova PLCANIK logoANIKAnika Therapeutic…LAKE logoLAKELakeland Industri…
Market CapShares × price$3.0B$1.9B$3.9B$203M$106M
Enterprise ValueMkt cap + debt − cash$4.4B$2.1B$3.7B$170M$120M
Trailing P/EPrice ÷ TTM EPS30.42x-13.80x-15.94x-19.92x-4.46x
Forward P/EPrice ÷ next-FY EPS est.13.55x16.84x
PEG RatioP/E ÷ EPS growth rate6.91x
EV / EBITDAEnterprise value multiple13.15x15.40x
Price / SalesMarket cap ÷ Revenue1.64x2.92x2.79x1.80x0.64x
Price / BookPrice ÷ Book value/share1.79x5.51x3.22x1.51x0.55x
Price / FCFMarket cap ÷ FCF28.78x22.40x46.51x
Evenly matched — ITGR and LAKE each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

LIVN leads this category, winning 5 of 9 comparable metrics.

LIVN delivers a 9.1% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-51 for NVCR. ANIK carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to NVCR's 0.85x. On the Piotroski fundamental quality scale (0–9), ANIK scores 6/9 vs LAKE's 3/9, reflecting solid financial health.

MetricITGR logoITGRInteger Holdings …NVCR logoNVCRNovoCure LimitedLIVN logoLIVNLivaNova PLCANIK logoANIKAnika Therapeutic…LAKE logoLAKELakeland Industri…
ROE (TTM)Return on equity+8.2%-50.8%+9.1%-7.7%-27.9%
ROA (TTM)Return on assets+4.2%-16.5%+4.2%-5.9%-17.0%
ROICReturn on invested capital+5.4%-16.4%+11.5%-7.1%-5.1%
ROCEReturn on capital employed+6.9%-28.9%+10.2%-6.4%-5.9%
Piotroski ScoreFundamental quality 0–955563
Debt / EquityFinancial leverage0.80x0.85x0.39x0.17x0.22x
Net DebtTotal debt minus cash$1.4B$187M-$162M-$33M$14M
Cash & Equiv.Liquid assets$17M$103M$636M$57M$17M
Total DebtShort + long-term debt$1.4B$290M$473M$24M$32M
Interest CoverageEBIT ÷ Interest expense5.07x-96.80x3.98x-23.38x
LIVN leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LIVN leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ITGR five years ago would be worth $9,252 today (with dividends reinvested), compared to $875 for NVCR. Over the past 12 months, LIVN leads with a +63.0% total return vs LAKE's -33.3%. The 3-year compound annual growth rate (CAGR) favors LIVN at 14.6% vs NVCR's -37.6% — a key indicator of consistent wealth creation.

MetricITGR logoITGRInteger Holdings …NVCR logoNVCRNovoCure LimitedLIVN logoLIVNLivaNova PLCANIK logoANIKAnika Therapeutic…LAKE logoLAKELakeland Industri…
YTD ReturnYear-to-date+14.5%+28.3%+17.0%+61.9%+22.5%
1-Year ReturnPast 12 months-26.1%+1.1%+63.0%+4.5%-33.3%
3-Year ReturnCumulative with dividends+8.8%-75.7%+50.5%-41.7%-4.0%
5-Year ReturnCumulative with dividends-7.5%-91.3%-14.5%-63.9%-58.3%
10-Year ReturnCumulative with dividends+165.1%+30.3%+46.2%-65.9%+34.0%
CAGR (3Y)Annualised 3-year return+2.9%-37.6%+14.6%-16.5%-1.3%
LIVN leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ITGR and LIVN each lead in 1 of 2 comparable metrics.

ITGR is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than NVCR's 2.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIVN currently trades 98.6% from its 52-week high vs LAKE's 52.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricITGR logoITGRInteger Holdings …NVCR logoNVCRNovoCure LimitedLIVN logoLIVNLivaNova PLCANIK logoANIKAnika Therapeutic…LAKE logoLAKELakeland Industri…
Beta (5Y)Sensitivity to S&P 5000.72x2.20x1.29x1.14x1.35x
52-Week HighHighest price in past year$123.78$20.06$71.92$16.24$20.50
52-Week LowLowest price in past year$62.00$9.82$39.36$7.87$7.15
% of 52W HighCurrent price vs 52-week peak+71.0%+83.9%+98.6%+93.2%+52.9%
RSI (14)Momentum oscillator 0–10050.969.857.653.350.8
Avg Volume (50D)Average daily shares traded628K1.5M808K135K100K
Evenly matched — ITGR and LIVN each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: ITGR as "Buy", NVCR as "Buy", LIVN as "Buy", ANIK as "Buy", LAKE as "Buy". Consensus price targets imply 99.0% upside for NVCR (target: $34) vs 7.0% for LIVN (target: $76). LAKE is the only dividend payer here at 1.10% yield — a key consideration for income-focused portfolios.

MetricITGR logoITGRInteger Holdings …NVCR logoNVCRNovoCure LimitedLIVN logoLIVNLivaNova PLCANIK logoANIKAnika Therapeutic…LAKE logoLAKELakeland Industri…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$98.00$33.50$75.88$14.00
# AnalystsCovering analysts14151469
Dividend YieldAnnual dividend ÷ price+1.1%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$0.12
Buyback YieldShare repurchases ÷ mkt cap+1.7%0.0%+0.1%+4.7%+0.4%
Insufficient data to determine a leader in this category.
Key Takeaway

LIVN leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.

Best OverallLivaNova PLC (LIVN)Leads 3 of 6 categories
Loading custom metrics...

ITGR vs NVCR vs LIVN vs ANIK vs LAKE: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ITGR or NVCR or LIVN or ANIK or LAKE a better buy right now?

For growth investors, Lakeland Industries, Inc.

(LAKE) is the stronger pick with 34. 1% revenue growth year-over-year, versus -5. 9% for Anika Therapeutics, Inc. (ANIK). Integer Holdings Corporation (ITGR) offers the better valuation at 30. 4x trailing P/E (13. 5x forward), making it the more compelling value choice. Analysts rate Integer Holdings Corporation (ITGR) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ITGR or NVCR or LIVN or ANIK or LAKE?

On forward P/E, Integer Holdings Corporation is actually cheaper at 13.

5x.

03

Which is the better long-term investment — ITGR or NVCR or LIVN or ANIK or LAKE?

Over the past 5 years, Integer Holdings Corporation (ITGR) delivered a total return of -7.

5%, compared to -91. 3% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: ITGR returned +165. 1% versus ANIK's -65. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ITGR or NVCR or LIVN or ANIK or LAKE?

By beta (market sensitivity over 5 years), Integer Holdings Corporation (ITGR) is the lower-risk stock at 0.

72β versus NovoCure Limited's 2. 20β — meaning NVCR is approximately 206% more volatile than ITGR relative to the S&P 500. On balance sheet safety, Anika Therapeutics, Inc. (ANIK) carries a lower debt/equity ratio of 17% versus 85% for NovoCure Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — ITGR or NVCR or LIVN or ANIK or LAKE?

By revenue growth (latest reported year), Lakeland Industries, Inc.

(LAKE) is pulling ahead at 34. 1% versus -5. 9% for Anika Therapeutics, Inc. (ANIK). On earnings-per-share growth, the picture is similar: Anika Therapeutics, Inc. grew EPS 80. 2% year-over-year, compared to -483. 6% for LivaNova PLC. Over a 3-year CAGR, LAKE leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ITGR or NVCR or LIVN or ANIK or LAKE?

Integer Holdings Corporation (ITGR) is the more profitable company, earning 5.

6% net margin versus -20. 8% for NovoCure Limited — meaning it keeps 5. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIVN leads at 14. 4% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ITGR or NVCR or LIVN or ANIK or LAKE more undervalued right now?

On forward earnings alone, Integer Holdings Corporation (ITGR) trades at 13.

5x forward P/E versus 16. 8x for LivaNova PLC — 3. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVCR: 99. 0% to $33. 50.

08

Which pays a better dividend — ITGR or NVCR or LIVN or ANIK or LAKE?

In this comparison, LAKE (1.

1% yield) pays a dividend. ITGR, NVCR, LIVN, ANIK do not pay a meaningful dividend and should not be held primarily for income.

09

Is ITGR or NVCR or LIVN or ANIK or LAKE better for a retirement portfolio?

For long-horizon retirement investors, Integer Holdings Corporation (ITGR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

72), +165. 1% 10Y return). NovoCure Limited (NVCR) carries a higher beta of 2. 20 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ITGR: +165. 1%, NVCR: +30. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ITGR and NVCR and LIVN and ANIK and LAKE?

These companies operate in different sectors (ITGR (Healthcare) and NVCR (Healthcare) and LIVN (Healthcare) and ANIK (Healthcare) and LAKE (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ITGR is a small-cap quality compounder stock; NVCR is a small-cap quality compounder stock; LIVN is a small-cap quality compounder stock; ANIK is a small-cap quality compounder stock; LAKE is a small-cap high-growth stock. LAKE pays a dividend while ITGR, NVCR, LIVN, ANIK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ITGR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

NVCR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Gross Margin > 45%
Run This Screen
Stocks Like

LIVN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 5%
Run This Screen
Stocks Like

ANIK

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Gross Margin > 35%
Run This Screen
Stocks Like

LAKE

Stable Dividend Mega-Cap

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ITGR and NVCR and LIVN and ANIK and LAKE on the metrics below

Revenue Growth>
%
(ITGR: 0.8% · NVCR: 12.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.